Group Belderbos

Medicijnen en Levenswetenschappen

1. Hematopoietic Stem Cells 100%
2. Leukemia 98%
3. Graft vs Host Disease 92%
4. Cell Transplantation 89%
5. Acute Myeloid Leukemia 83%
6. Human Adenovirus Infections 75%
7. Allogeneic Cells 71%
8. CRISPR-Associated Protein 9 68%
9. Pediatrics 67%
10. T-Lymphocytes 61%
11. Hematopoiesis 58%
12. Human Adenoviruses 58%
13. Gene Editing 53%
14. Cytoprotection 52%
15. Clustered Regularly Interspaced Short Palindromic Repeats 50%
16. Bone Marrow 50%
17. Heterografts 49%
18. Mutation 49%
19. Clone Cells 44%
20. Immunotherapy 43%
21. Fetal Blood 43%
22. Organoids 43%
23. Precursor Cell Lymphoblastic Leukemia-Lymphoma 43%
24. Natural Killer Cells 40%
25. HLA-Bw4 antigen 39%
26. Dendritic Cells 39%
27. Neutrophils 34%
28. Hematopoietic Stem Cell Transplantation 30%
29. Drug Therapy 29%
30. Survival 24%
31. Mortality 19%
32. Child 19%
33. Transplantation Conditioning 17%
34. Therapeutics 16%
35. Data Analysis 16%
36. Phenotype 16%
37. Methotrexate 15%
38. Cell- and Tissue-Based Therapy 15%
39. Natural Killer Cell Receptors 15%
40. Immunogenetics 14%
41. HLA-B Antigens 14%
42. Chimerism 13%
43. HLA-A Antigens 13%
44. Cell Count 12%
45. Neoplasms 12%
46. Viremia 12%
47. Tissue Donors 12%
48. Vincristine 11%
49. Immunocompromised Host 11%
50. Patient Care 11%
51. Chromatin 11%
52. Dexamethasone 10%
53. Noise 10%
54. Morbidity 9%
55. Libraries 9%
56. Transcription Factors 9%
57. Transfection 9%
58. Regeneration 9%
59. Erythroid Cells 7%
60. Population 7%
61. Epithelial Cells 7%
62. Neoplasm Antigens 7%
63. Ligands 7%
64. Immune Reconstitution 7%
65. Technology 7%
66. Zinc Fingers 7%
67. Bone Marrow Cells 6%
68. Ribonucleoproteins 6%
69. Electroporation 6%
70. Polymerase Chain Reaction 6%
71. Recurrence 6%
72. Microbiota 6%
73. Hematologic Neoplasms 5%
74. Epigenomics 5%
75. Secondary Prevention 5%
76. Osteoblasts 5%
77. Adipocytes 5%
78. Monocytes 5%